Stop Pills That Kill Act
The source supplies the latest action, but no lifecycle stage.
Latest action (16 Sep 2026): Received in the Senate and Read twice and referred to the Committee on the Judiciary.
What this bill does
The Stop Pills That Kill Act would amend the Controlled Substances Act to tighten federal oversight of tableting and encapsulating machines—equipment used to press powders into pills—and their critical parts, such as dies and punches. It expands the definition of "regulated person" to cover manufacturers, distributors, importers, exporters, and brokers of these machines and parts, requires permanent serial numbers on them, and mandates reporting of related transactions to the Attorney General. The bill creates new federal crimes for removing or altering serial numbers, or for knowingly trafficking in machines with tampered numbers. It also extends U.S. jurisdiction to reach foreign manufacture or distribution of such machines intended for illicit drug production and unlawful importation into the United States, with penalties of up to 20 years depending on the offense, and directs the U.S. Sentencing Commission to update sentencing guidelines accordingly.
The bill primarily affects manufacturers, distributors, importers, and sellers of pill-pressing equipment, who would face new recordkeeping, serial-number, and reporting requirements, as well as individuals or organizations involved in trafficking counterfeit pills containing substances like fentanyl or methamphetamine. It also directs the Drug Enforcement Administration to create an operational plan to address counterfeit pills containing illicit synthetic substances, including education efforts, and requires annual reports to Congress through fiscal year 2031 on seizures, prosecutions, and prevention measures.
The bill passed the House on September 15, 2026, by voice vote and now goes to the Senate for consideration. It has not yet been voted on by the Senate or signed into law.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
Stop Pills That Kill Act
This bill increases criminal penalties for offenses relating to the manufacture of fentanyl or counterfeit substances. It also establishes requirements for federal agencies to address the use of counterfeit substances.
Specifically, the bill applies an increased criminal penalty for possessing, manufacturing, or distributing certain equipment or materials that are used to illegally manufacture fentanyl, an analogue of fentanyl, or a counterfeit substance (the increased penalty is currently limited to offenses involving methamphetamine).
The Drug Enforcement Administration must establish and implement a plan to address counterfeit fentanyl or methamphetamine substances through law enforcement action and education and prevention efforts. In addition, the Department of Justice must annually report on the collection of counterfeit fentanyl or methamphetamine substances by law enforcement and on related prosecutions.
Timeline
16 Sep 2026
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Common questions
- What does H.R. 8005 do?
- The Stop Pills That Kill Act would amend the Controlled Substances Act to tighten federal oversight of tableting and encapsulating machines—equipment used to press powders into pills—and their critical parts, such as dies and punches. It expands the definition of "regulated person" to cover manufacturers, distributors, importers, exporters, and brokers of these machines and parts, requires permanent serial numbers on them, and mandates reporting of related transactions to the Attorney General. The bill creates new federal crimes for removing or altering serial numbers, or for knowingly trafficking in machines with tampered numbers. It also extends U.S. jurisdiction to reach foreign manufacture or distribution of such machines intended for illicit drug production and unlawful importation into the United States, with penalties of up to 20 years depending on the offense, and directs the U.S. Sentencing Commission to update sentencing guidelines accordingly. The bill primarily affects manufacturers, distributors, importers, and sellers of pill-pressing equipment, who would face new recordkeeping, serial-number, and reporting requirements, as well as individuals or organizations involved in trafficking counterfeit pills containing substances like fentanyl or methamphetamine. It also directs the Drug Enforcement Administration to create an operational plan to address counterfeit pills containing illicit synthetic substances, including education efforts, and requires annual reports to Congress through fiscal year 2031 on seizures, prosecutions, and prevention measures. The bill passed the House on September 15, 2026, by voice vote and now goes to the Senate for consideration. It has not yet been voted on by the Senate or signed into law.
- Has H.R. 8005 become law?
- The source does not supply a confirmed lifecycle stage for H.R. 8005. Check the latest action and official source below.
- Who sponsored H.R. 8005?
- H.R. 8005 was sponsored by Rep. Evans, Gabe [R-CO-8] (R-CO), with 0 cosponsors.
- What's the latest action on H.R. 8005?
- Received in the Senate and Read twice and referred to the Committee on the Judiciary. (16 Sep 2026).
Related bills in Crime and Law Enforcement
Enhancing Detection of Human Trafficking Act
National Coordination Center and Commercial Cyber Capabilities Codification Act
Anthony Amoros Law Right to Know Act
Supporting the goals and ideals of "National Nonviolence Week" to raise awareness of youth violence in the United States.
More bills from Rep. Evans, Gabe [R-CO-8]
To amend the Federal Crop Insurance Act to require certain types of cattle to be included in a livestock pilot program, and for other purposes.
Expressing support for American animal agriculture and recognizing its integral role in strengthening food security, lowering food costs, and reinforcing economic growth in the United States.
STOP Medicaid Fraud Act of 2026
Expressing support for the designation of the week of September 13 to 19, 2026, as "National Co-Responder and Crisis Clinician Week".
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.